FDA 483 - VEOS USA, Inc. - September 03, 2025

An FDA inspection of VEOS USA, Inc. in Adrian, MI, a manufacturer of egg products, revealed significant deficiencies in preventive controls and environmental monitoring. The firm failed to adequately pasteurize liquid raw egg ingredients to control Salmonella and Enterobacteriaceae, and did not maintain proper environmental monitoring or temperature controls for raw egg storage. These issues indicate a high potential for product contamination and include a repeat observation regarding preventive controls.